Investing.com — Apple Inc (NASDAQ:AAPL). has terminated its project to develop an iPhone hardware subscription service, according to sources close to the matter. The service aimed to let consumers pay…
Stock
Investing.com — Russian President Vladimir Putin expressed his readiness to engage in dialogue with US President-elect Donald Trump, despite the fact that they haven’t communicated in over four years. During…
Amazon workers go on strike in US ahead of Christmas rush as union seeks contract talks
(Reuters) – Amazon.com (NASDAQ:AMZN) workers at seven U.S. facilities walked off the job early on Thursday during the holiday shopping rush, aiming to pressure the retailer into contract talks with…
Investing.com — Hong Kong Exchanges & Clearing Ltd. (HKEX) is looking to modify some of its initial public offering (IPO) requirements. This move comes as the city aims to revamp…
Investing.com — European markets traded in mixed fashion on Wednesday as investors await key developments from the U.S. Federal Reserve. As of 3:13 ET (8:13 GMT), Germany’s DAX index was…
Investing.com — Siemens AG (OTC:SIEGY) intends to sell a $2.6 billion stake in Siemens Energy AG (ETR:ENR1n) in the forthcoming months. The sale is part of the company’s strategy to…
Investing.com — Meta Platforms Inc (NASDAQ:META).’s Instagram is projected to comprise 50% of the company’s US advertising revenue in the near future, as per Emarketer’s estimates. This prediction underscores Instagram’s…
Renault open in principle to Nissan pursuing merger talks with Honda, sources say
(Reuters) -French automaker Renault (EPA:RENA), Nissan (OTC:NSANY) Motor’s largest shareholder, is open in principle to the Japanese automaker pursuing merger talks with peer Honda (NYSE:HMC) Motor, two people familiar with…
(Reuters) -Birkenstock beat market expectations for fourth-quarter revenue on Wednesday, helped by robust full-price sales of the German footwear maker’s pricey sandals in the United States and Asia. With fresh…
Investing.com — The European Medicines Agency (EMA), the European Union’s drug regulator, has announced a review of two scientific studies that suggest a connection between Novo Nordisk (NYSE:NVO)’s popular diabetes…